Recurrent GBM brain tumors with few mutations respond best to immunotherapy
Glioblastoma brain tumors are especially perplexing. Inevitably lethal, the tumors occasionally respond to new immunotherapies after they’ve grown back, enabling
Read more
Few at risk for diabetes report being informed by provider
(HealthDay)—Few patients with undiagnosed prediabetes are told that they are at high risk for diabetes, according to a study published
Read more